Your markets
Pharmaceutical & Biotechnology
Your custom designed and constructed pharmaceutical and biopharmaceutical facilities
Your challenges
High-performance and reliable facilities to meet the challenges of global health
Your applications
Our custom-built installations meet the specific requirements of your products
PHARMACEUTICAL PRODUCTS
Syrups and oral forms
Creams, ointments
and skin treatments
Injectable and ophthalmic solutions
BIOTECHNOLOGY SOLUTIONS
and polyclonal antibodies
BLOOD FRACTIONATION
OUR SOLUTIONS
Our equipment and facilities are custom designed to meet your needs
Turnkey plants
Project management
Process Engineering
Our tailor-made skids
Our products
We design and manufacture equipment to meet your projects
- Storage and distribution of bulk raw material
- Clean utilities : Process water, Clean steam
- Standard skids of bulk production (500 kg to 20 T )
- Storage systems of semi-finished products with scraping station
- CIP stations
- Ultra-filtration modules
- Bioreactor / Fermentor
- Mixing and process tanks
- Chromatography modules
- Water loops
Our services
We support you throughout the life cycle of your installations
Whether directly on site or remotely, we ensure that your installations are maintained at their best performance in complete safety.
Our “Technologies & Services” service dedicated to the pharmaceutical and biotechnology markets supports you in maintaining, upgrading and maintaining the performance of your installations.
MAINTENANCE & SPARE PARTS
UPGRADING & MODERNIZATION
PERFORMANCE & OPTIMIZATION
Focus on TrackAdvance
Our achievements
For the Pharmaceutical & Biotechnology industries
Boccard at CEBioFORUM 2026 | Warsaw
Boccard at the Pitch Sessions during CEBioForum 2026 Meet the innovators shaping the future of life sciences. At this year’s CEBioForum 2026, taking place onApril
Industrial Insulin Production Explained: Technology, Purification and Aseptic Formulation
As global diabetes prevalence continues to rise, insulin production must scale while meeting strict GMP and sterility requirements. This case study explores how industrial insulin manufacturing is designed, from biotechnology to aseptic formulation, and how Boccard supported a major producer in reinforcing formulation capacity.
Scaling up GLP-1 Production to Meet Global Demand: Boccard’s Contribution to a High-Growth Therapeutic Segment
As demand for GLP‑1 therapies grows in obesity and Type 2 diabetes care, manufacturers must rapidly scale production while meeting strict GMP requirements. This case study shows how Boccard delivered a robust and scalable GLP‑1 production line.
You have a project ?
Our Customers
They trust us
